COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson's disease

被引：0
|
作者：
Akhmadeeva, G.
Khidiyatova, I.
Gilyazova, I.
Umutbaev, S.
Kachemaeva, O.
Baitimerov, A.
Galimova, R.
Magzhanov, R.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1278
引用
收藏
页码：S560 / S561
页数：2
相关论文
共 50 条
  • [1] Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease
    Ivanova, S. A.
    Alifirova, V. M.
    Freidin, M. B.
    Pozhidaev, I. V.
    Fedorenko, O. Y.
    Bokhan, N. A.
    Zhukova, I. A.
    Zhukova, N. G.
    Wilffert, B.
    Loonen, A. J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1039 - S1040
  • [2] Levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    Lee, J
    Venderova, K
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (03) : 359 - 391
  • [3] Levodopa-induced dyskinesia in Parkinson’s disease
    J. M. Brotchie
    J. Lee
    K. Venderova
    Journal of Neural Transmission, 2005, 112 : 359 - 391
  • [4] The study of the role of genetic risk factors in levodopa-induced dyskinesia development in Russian patients with Parkinson's disease: a pilot study
    Akhmadeeva, G.
    Khidiyatova, I.
    Gilyazova, I.
    Baitimerov, A.
    Tayupova, G.
    Magzhanov, R.
    MOVEMENT DISORDERS, 2020, 35 : S193 - S193
  • [5] COMT polymorphism in development of levodopa-induced dyskinesia in Korean Parkinson's disease patients: Case control study of 178 patients based on genetic predictors in Parkinson's disease progression (GEPIP) cohort.
    Park, Sea Mi
    Lee, Myoung Chong
    Cho, A-Hyun
    Lim, Jiyoung
    Song, Kyuyoung
    ANNALS OF NEUROLOGY, 2006, 60 (05) : 643 - 643
  • [6] The human M-opioid receptor genes polymorphism is not associated with levodopa-induced dyskinesia development in Russian patients with Parkinson's disease
    Akhmadeeva, Gulnara
    Khidiyatova, Irina
    Gilyazova, Irina
    Tayupova, Gulnaz
    Umutbaev, Salavat
    Baitimerov, Azamat
    Magjanov, Rim
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 323 - 324
  • [7] Levodopa-induced ocular dyskinesia in Parkinson's disease
    Groetzsch, H.
    Sztajzel, R.
    Burkhard, P. R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (10) : 1124 - 1128
  • [8] Effect of Safinamide on Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
    Bhatt, Mohit
    Chirileanu, Dana
    Meshram, Chandrashekhar
    Stanzione, Paolo
    Forrest, Emma C.
    NEUROLOGY, 2010, 74 (09) : A319 - A319
  • [9] Risk factors for levodopa-induced dyskinesia in Parkinson's disease patients
    Djuric, Gordana
    Markovic, Vladana
    Pekmezovic, Tatjana
    Tomic, Aleksandra
    Kresojevic, Nikola
    Kostic, Vladimir
    Svetel, Marina
    VOJNOSANITETSKI PREGLED, 2017, 74 (10) : 921 - 926
  • [10] Pridopidine for the treatment of Levodopa-induced Dyskinesia in patients with Parkinson's disease
    Geva, M.
    McGarry, A.
    Cohen, Y.
    Johnston, T.
    de Somer, M.
    Kieburtz, K.
    Hayden, M.
    Brotchie, J.
    Olanow, C.
    MOVEMENT DISORDERS, 2020, 35 : S396 - S396
12345